InsidersTradesSigma
Track the Hikma Pharmaceuticals PLC stock price and the full management transaction log of the company, a publicly traded company based in United Kingdom. Shares trade on the UK market, under the supervision of RNS (LSE). Market capitalisation: €3.4bn. The latest transaction was filed on 11 August 2026 (Purchase). Among the most active insiders: Susan Ringdal. Every trade is free.
121
Insider Decl.
n/a
Thresholds
€15m
56 ops.
Buy Volume
€2m
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Hikma Pharmaceuticals PLC Strong Buy (bullish), based on 12 analysts. Average price target: £1,877.98.
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,323 of 29,063 companies
72.5
score / 100
Value79
Quality66
FCF yld3.6%
Earn yld12%
EV/EBITDA5.9x
ROE15%
Gross mgn43%
Net mgn12%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 August 2026
Declarations121 total
7,500 shares@ £16.480.0036% mcap100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083FCA-NSM:401d4065-a416-48a1-82d5-78e886f836e8
7,500 shares@ £16.48250.0000% mcap0.0% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9715760
38,222 shares@ £14.4920.1% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9597628-5
0London Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9597628-0
0London Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9597628-3
0London Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9597628-4
0London Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9597628-1
0London Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9597628-2
76,444 shares@ £14.4920.1% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-5
73,622 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-3
41,037 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-4
111,573 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-0
93,413 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-1
73,859 sharesLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:d44dbdfb-743e-4c57-a372-497ad09925dd-2
2,337 shares@ £14.0981.2% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:549f9a76-e199-4690-8f52-59ddfd93c657-1
407 shares@ £14.0986.3% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:549f9a76-e199-4690-8f52-59ddfd93c657-0
178 shares@ £14.0981.8% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:549f9a76-e199-4690-8f52-59ddfd93c657-2
14,455 shares@ £13.7666.7% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:7e577389-dfc6-4254-b481-e9f10701b63b
11,309 shares@ £13.0928.8% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:20a6a8b1-a14c-4475-9249-b33a586e281e-0
49,502 sharesOutside a trading venueISIN GB00B0LCW083RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-5
59,221 sharesOutside a trading venueISIN GB00B0LCW083RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-3
88,860 sharesOutside a trading venueISIN GB00B0LCW083RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-4
40,043 sharesOutside a trading venueISIN GB00B0LCW083RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-6
87,317 sharesOutside a trading venueISIN GB00B0LCW083RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-7
25 of 121 declarations
关于 Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC 是一家总部位于英国的制药公司，专门从事仿制药和品牌药的生产。它主要在英国和国际市场运营，提供创新的医疗保健解决方案。